Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2010, Article ID 821940, 9 pages
http://dx.doi.org/10.1155/2010/821940
Research Article

Activation of CD147 with Cyclophilin A Induces the Expression of IFITM1 through ERK and PI3K in THP-1 Cells

1School of Life Sciences and Biotechnology, Kyungpook National University, Daegu 702-701, Republic of Korea
2Department of Pharmacology, School of Medicine, Kyungpook National University, Daegu 702-701, Republic of Korea

Received 11 May 2010; Revised 29 June 2010; Accepted 30 June 2010

Academic Editor: Steven Kunkel

Copyright © 2010 Ju-Young Kim et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. L. Friedman, S. P. Manly, M. McMahon, I. M. Kerr, and G. R. Stark, “Transcriptional and posttranscriptional regulation of interferon-induced gene expression in human cells,” Cell, vol. 38, no. 3, pp. 745–755, 1984. View at Google Scholar · View at Scopus
  2. S. S. Evans, R. P. Collea, J. A. Leasure, and D. B. Lee, “IFN-α induces homotypic adhesion and Leu-13 expression in human B lymphoid cells,” Journal of Immunology, vol. 150, no. 3, pp. 736–747, 1993. View at Google Scholar · View at Scopus
  3. T. Imai and O. Yoshie, “C33 antigen and M38 antigen recognized by monoclonal antibodies inhibitory to syncytium formation by human T cell leukemia virus type 1 are both members of the transmembrane 4 superfamily and associate with each other and with CD4 or CD8 in T cells,” Journal of Immunology, vol. 151, no. 11, pp. 6470–6481, 1993. View at Google Scholar · View at Scopus
  4. U. C. Lange, M. Saitou, P. S. Western, S. C. Barton, and M. A. Surani, “The fragilis interferon-inducible gene family of transmembrane proteins is associated with germ cell specification in mice,” BMC Developmental Biology, vol. 3, article 1, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. R. A. Smith, J. Young, J. J. Weis, and J. H. Weis, “Expression of the mouse fragilis gene products in immune cells and association with receptor signaling complexes,” Genes and Immunity, vol. 7, no. 2, pp. 113–121, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. S. S. Tanaka, Y. L. Yamaguchi, B. Tsoi, H. Lickert, and P. P. L. Tam, “IFITM/Mil/fragilis family proteins IFITM1 and IFITM3 play distinct roles in mouse primordial germ cell homing and repulsion,” Developmental Cell, vol. 9, no. 6, pp. 745–756, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. A. L. Brass, I.-C. Huang, Y. Benita et al., “The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, west nile virus, and dengue virus,” Cell, vol. 139, no. 7, pp. 1243–1254, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Hatano, Y. Kudo, I. Ogawa et al., “IFN-induced transmembrane protein 1 promotes invasion at early stage of head and neck cancer progression,” Clinical Cancer Research, vol. 14, no. 19, pp. 6097–6105, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. M. Ma, B. P. Wu, and O. D. Xia, “Expression and significance of interferon-inducible transmembrane protein-1 gene in Peutz-Jeghers syndrome,” Journal of Southern Medical University, vol. 29, no. 3, pp. 541–543, 2009. View at Google Scholar
  10. K. F. Chambers, J. R. Bacon, E. K. Kemsley et al., “Gene expression profile of primary prostate epithelialand stromal cells in response to sulforaphane or iberin exposure,” Prostate, vol. 69, no. 13, pp. 1411–1421, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. H. Liu, J. Lin, J. Guo et al., “Detection of interferon-induced transmembrane-1 gene expression for clinical diagnosis of colorectal cancer,” Journal of Southern Medical University, vol. 28, no. 11, pp. 1950–1953, 2008. View at Google Scholar
  12. R. K. Nibbe, S. Markowitz, L. Myeroff, R. Ewing, and M. R. Chance, “Discovery and scoring of protein interaction subnetworks discriminative of late stage human colon cancer,” Molecular & Cellular Proteomics, vol. 8, no. 4, pp. 827–845, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. C. Biswas, Y. Zhang, R. DeCastro et al., “The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily,” Cancer Research, vol. 55, no. 2, pp. 434–439, 1995. View at Google Scholar · View at Scopus
  14. C. Biswas, “Tumor cell stimulation of collagenase production by fibroblasts,” Biochemical and Biophysical Research Communications, vol. 109, no. 3, pp. 1026–1034, 1982. View at Google Scholar · View at Scopus
  15. W. Kasinrerk, E. Fiebiger, I. Stefanova, T. Baumruker, W. Knapp, and H. Stockinger, “Human leukocyte activation antigen M6, a member of the Ig superfamily, is the species homologue of rat OX-47, mouse basigin, and chicken HT7 molecule,” Journal of Immunology, vol. 149, no. 3, pp. 847–854, 1992. View at Google Scholar · View at Scopus
  16. K. Nabeshima, W. S. Lane, and C. Biswas, “Partial sequencing and characterization of the tumor cell-derived collagenase stimulatory factor,” Archives of Biochemistry and Biophysics, vol. 285, no. 1, pp. 90–96, 1991. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Caudroy, M. Polette, B. Nawrocki-Raby et al., “EMMPRIN-mediated MMP regulation in tumor and endothelial cells,” Clinical and Experimental Metastasis, vol. 19, no. 8, pp. 697–702, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Tang, M. T. Nakada, P. Kesavan et al., “Extracellular matrix metalloproteinase inducer stimulates tumor angiogenesis by elevating vascular endothelial cell growth factor and matrix metalloproteinases,” Cancer Research, vol. 65, no. 8, pp. 3193–3199, 2005. View at Google Scholar · View at Scopus
  19. H. D. Foda, E. E. Rollo, M. Drews et al., “Ventilator-induced lung injury upregulates and activates gelatinases and EMMPRIN: attenuation by the synthetic matrix metalloproteinase inhibitor, prinomastat (AG3340),” American Journal of Respiratory Cell and Molecular Biology, vol. 25, no. 6, pp. 717–724, 2001. View at Google Scholar · View at Scopus
  20. Y. T. Konttinen, T.-F. Li, J. Mandelin et al., “Increased expression of extracellular matrix metalloproteinase inducer in rheumatoid synovium,” Arthritis and Rheumatism, vol. 43, no. 2, pp. 275–280, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. T. C. Major, L. Liang, X. Lu, W. Rosebury, and T. M. A. Bocan, “Extracellular matrix metalloproteinase inducer (EMMPRIN) is induced upon monocyte differentiation and is expressed in human atheroma,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 22, no. 7, pp. 1200–1207, 2002. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Pushkarsky, G. Zybarth, L. Dubrovsky et al., “CD147 facilitates HIV-1 infection by interacting with virus-associated cyclophilin A,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 11, pp. 6360–6365, 2001. View at Publisher · View at Google Scholar · View at Scopus
  23. V. Yurchenko, M. O'Connor, W. W. Dai et al., “CD147 is a signaling receptor for cyclophilin B,” Biochemical and Biophysical Research Communications, vol. 288, no. 4, pp. 786–788, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. B. Sherry, N. Yarlett, A. Strupp, and A. Cerami, “Identification of cyclophilin as a proinflammatory secretory product of lipopolysaccharide-activated macrophages,” Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 8, pp. 3511–3515, 1992. View at Google Scholar · View at Scopus
  25. Z.-G. Jin, A. O. Lungu, L. Xie, M. Wang, C. Wong, and B. C. Berk, “Cyclophilin A is a proinflammatory cytokine that activates endothelial cells,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 24, no. 7, pp. 1186–1191, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. Z.-G. Jin, M. G. Melaragno, D.-F. Liao et al., “Cyclophilin A is a secreted growth factor induced by oxidative stress,” Circulation Research, vol. 87, no. 9, pp. 789–796, 2000. View at Google Scholar · View at Scopus
  27. S.-H. Kim, S. M. Lessner, Y. Sakurai, and Z. S. Galis, “Cyclophilin A as a novel biphasic mediator of endothelial activation and dysfunction,” American Journal of Pathology, vol. 164, no. 5, pp. 1567–1574, 2004. View at Google Scholar · View at Scopus
  28. H. Kim, W.-J. Kim, S.-T. Jeon et al., “Cyclophilin A may contribute to the inflammatory processes in rheumatoid arthritis through induction of matrix degrading enzymes and inflammatory cytokines from macrophages,” Clinical Immunology, vol. 116, no. 3, pp. 217–224, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. Y. Yang, N. Lu, J. Zhou, Z.-N. Chen, and P. Zhu, “Cyclophilin A up-regulates MMP-9 expression and adhesion of monocytes/ macrophages via CD147 signalling pathway in rheumatoid arthritis,” Rheumatology, vol. 47, no. 9, pp. 1299–1310, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. J. M. Damsker, M. I. Bukrinsky, and S. L. Constant, “Preferential chemotaxis of activated human CD4+ T cells by extracellular cyclophilin A,” Journal of Leukocyte Biology, vol. 82, no. 3, pp. 613–618, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. I. Tegeder, A. Schumacher, S. John et al., “Elevated serum cyclophilin levels in patients with severe sepsis,” Journal of Clinical Immunology, vol. 17, no. 5, pp. 380–386, 1997. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Billich, G. Winkler, H. Aschauer, A. Rot, and P. Peichl, “Presence of cyclophilin A in synovial fluids of patients with rheumatoid arthritis,” Journal of Experimental Medicine, vol. 185, no. 5, pp. 975–980, 1997. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Y. Kim, W. J. Kim, H. Kim, K. Suk, and W. H. Lee, “The stimulation of CD147 induces MMP-9 expression through ERK and NF-kappaB in macrophages: implication for atherosclerosis,” Immune Network, vol. 9, no. 3, pp. 90–97, 2009. View at Google Scholar
  34. R. Schmidt, A. Bültmann, M. Ungerer et al., “Extracellular matrix metalloproteinase inducer regulates matrix metalloproteinase activity in cardiovascular cells: implications in acute myocardial infarction,” Circulation, vol. 113, no. 6, pp. 834–841, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. K. Watashi, N. Ishii, M. Hijikata et al., “Cyclophilin B is a functional regulator of hepatitis C virus RNA polymerase,” Molecular Cell, vol. 19, no. 1, pp. 111–122, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. S. K.-H. Swanson, T. Born, L. D. Zydowsky et al., “Cyclosporin-mediated inhibition of bovine calcineurin by cyclophilins A and B,” Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 9, pp. 3741–3745, 1992. View at Google Scholar · View at Scopus
  37. T. Smith, L. R. Ferreira, C. Hebert, K. Norris, and J. J. Sauk, “Hsp47 and cyclophilin B traverse the endoplasmic reticulum with procollagen into pre-Golgi intermediate vesicles. A role for Hsp47 and cyclophilin B in the export of procollagen from the endoplasmic reticulum,” Journal of Biological Chemistry, vol. 270, no. 31, pp. 18323–18328, 1995. View at Publisher · View at Google Scholar · View at Scopus
  38. M. A. Rycyzyn, S. C. Reilly, K. O'Malley, and C. V. Clevenger, “Role of cyclophilin B in prolactin signal transduction and nuclear retrotranslocation,” Molecular Endocrinology, vol. 14, no. 8, pp. 1175–1186, 2000. View at Publisher · View at Google Scholar · View at Scopus
  39. E. Roydon Price, L. D. Zydowsky, M. Jin, C. Hunter Baker, F. D. Mckeon, and C. T. Walsh, “Human cyclophilin B: a second cyclophilin gene encodes a peptidyl-prolyl isomerase with a signal sequence,” Proceedings of the National Academy of Sciences of the United States of America, vol. 88, no. 5, pp. 1903–1907, 1991. View at Google Scholar · View at Scopus
  40. M. I. Bukrinsky, “Cyclophilins: unexpected messengers in intercellular communications,” Trends in Immunology, vol. 23, no. 7, pp. 323–325, 2002. View at Publisher · View at Google Scholar · View at Scopus
  41. C. Mariller, F. Allain, M. Kouach, and G. Spik, “Evidence that human milk isolated cyclophilin B corresponds to a truncated form,” Biochimica et Biophysica Acta, vol. 1293, no. 1, pp. 31–38, 1996. View at Publisher · View at Google Scholar · View at Scopus
  42. F. De Ceuninck, F. Allain, A. Caliez, G. Spik, and P. M. Vanhoutte, “High binding capacity of cyclophilin B to chondrocyte heparan sulfate proteoglycans and its release from the cell surface by matrix metalloproteinases: possible role as a proinflammatory mediator in arthritis,” Arthritis and Rheumatism, vol. 48, no. 8, pp. 2197–2206, 2003. View at Publisher · View at Google Scholar · View at Scopus
  43. C. Bonny, A. Oberson, S. Negri, C. Sauser, and D. F. Schorderet, “Cell-permeable peptide inhibitors of JNK. Novel blockers of β-cell death,” Diabetes, vol. 50, no. 1, pp. 77–82, 2001. View at Google Scholar · View at Scopus
  44. S. Tsuchiya, M. Yamabe, Y. Yamaguchi, Y. Kobayashi, T. Konno, and K. Tada, “Establishment and characterization of a human acute monocytic leukemia cell line (THP-1),” International Journal of Cancer, vol. 26, no. 2, pp. 171–176, 1980. View at Google Scholar · View at Scopus
  45. W.-H. Lee, S.-H. Kim, Y. Lee et al., “Tumor necrosis factor receptor superfamily 14 is involved in atherogenesis by inducing proinflammatory cytokines and matrix metalloproteinases,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 21, no. 12, pp. 2004–2010, 2001. View at Google Scholar · View at Scopus
  46. S.-H. Kim, Y.-J. Kang, W.-J. Kim et al., “TWEAK can induce pro-inflammatory cytokines and matrix metalloproteinase-9 in macrophages,” Circulation Journal, vol. 68, no. 4, pp. 396–399, 2004. View at Publisher · View at Google Scholar · View at Scopus
  47. Y.-J. Kim, C.-I. Kwak, Y.-Y. Gu, I.-T. Hwang, and J.-Y. Chun, “Annealing control primer system for identification of differentially expressed genes on agarose gels,” BioTechniques, vol. 36, no. 3, pp. 424–434, 2004. View at Google Scholar · View at Scopus
  48. S. M. Ellis, K. Nabeshima, and C. Biswas, “Monoclonal antibody preparation and purification of a tumor cell collagenase-stimulatory factor,” Cancer Research, vol. 49, no. 12, pp. 3385–3391, 1989. View at Google Scholar · View at Scopus
  49. H. Kataoka, R. DeCastro, S. Zucker, and C. Biswas, “Tumor cell-derived collagenase-stimulatory factor increases expression of interstitial collagenase, stromelysin, and 72-kDa gelatinase,” Cancer Research, vol. 53, no. 13, pp. 3154–3158, 1993. View at Google Scholar · View at Scopus
  50. M. Lim, T. Martinez, D. Jablons et al., “Tumor-derived EMMPRIN (extracellular matrix metalloproteinase inducer) stimulates collagenase transcription through MAPK p38,” FEBS Letters, vol. 441, no. 1, pp. 88–92, 1998. View at Publisher · View at Google Scholar · View at Scopus
  51. E. M. Bae, W.-J. Kim, K. Suk et al., “Reverse signaling initiated from GITRL induces NF-κB activation through ERK in the inflammatory activation of macrophages,” Molecular Immunology, vol. 45, no. 2, pp. 523–533, 2008. View at Publisher · View at Google Scholar · View at Scopus
  52. P. Requena, A. Daddaoua, E. Guadix et al., “Bovine glycomacropeptide induces cytokine production in human monocytes through the stimulation of the MAPK and the NF-κB signal transduction pathways,” British Journal of Pharmacology, vol. 157, no. 7, pp. 1232–1240, 2009. View at Publisher · View at Google Scholar · View at Scopus
  53. C. Song, K. Hsu, E. Yamen et al., “Serum amyloid A induction of cytokines in monocytes/macrophages and lymphocytes,” Atherosclerosis, vol. 207, no. 2, pp. 374–383, 2009. View at Publisher · View at Google Scholar · View at Scopus
  54. A. Gaurnier-Hausser, V. L. Rothman, S. Dimitrov, and G. P. Tuszynski, “The novel angiogenic inhibitor, angiocidin, induces differentiation of monocytes to macrophages,” Cancer Research, vol. 68, no. 14, pp. 5905–5914, 2008. View at Publisher · View at Google Scholar · View at Scopus
  55. Y. Xu, G. Yang, and G. Hu, “Binding of IFITM1 enhances the inhibiting effect of caveolin-1 on ERK activation,” Acta Biochimica et Biophysica Sinica, vol. 41, no. 6, pp. 488–494, 2009. View at Publisher · View at Google Scholar · View at Scopus
  56. H. Yang, J. Chen, J. Yang, S. Qiao, S. Zhao, and L. Yu, “Cyclophilin A is upregulated in small cell lung cancer and activates ERK1/2 signal,” Biochemical and Biophysical Research Communications, vol. 361, no. 3, pp. 763–767, 2007. View at Publisher · View at Google Scholar · View at Scopus
  57. P. Libby, “Inflammation in atherosclerosis,” Nature, vol. 420, no. 6917, pp. 868–874, 2002. View at Publisher · View at Google Scholar · View at Scopus
  58. P. Libby, Y. J. Geng, M. Aikawa et al., “Macrophages and atherosclerotic plaque stability,” Current Opinion in Lipidology, vol. 7, no. 5, pp. 330–335, 1996. View at Google Scholar · View at Scopus